Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-dose chemotherapy regimens for solid tumors

E van der Wall1, J H Beijnen, S Rodenhuis

  • 1Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam.

Cancer Treatment Reviews
|March 1, 1995
PubMed
Summary

High-dose chemotherapy with blood progenitor cell transplantation offers potential for solid tumors. Careful drug selection is crucial to manage extramedullary toxicity and optimize patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor infiltrating lymphocytes and change in tumor load on MRI to assess response and prognosis after neoadjuvant chemotherapy in breast cancer.

Breast cancer research and treatment·2024
Same author

Author Correction: Clinical implementation of artificial-intelligence-assisted detection of breast cancer metastases in sentinel lymph nodes: the CONFIDENT-B single-center, non-randomized clinical trial.

Nature cancer·2024
Same author

Clinical implementation of artificial-intelligence-assisted detection of breast cancer metastases in sentinel lymph nodes: the CONFIDENT-B single-center, non-randomized clinical trial.

Nature cancer·2024
Same author

Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer.

ESMO open·2024
Same author

Predicting response to neoadjuvant chemotherapy with liquid biopsies and multiparametric MRI in patients with breast cancer.

NPJ breast cancer·2024
Same author

Author Correction: Possible alleviation of symptoms and side effects through clinicians' nocebo information and empathy in an experimental video vignette study.

Scientific reports·2023

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • High-dose chemotherapy with blood progenitor cell transplantation is a recognized treatment for various solid tumors.
  • Alkylating agents are frequently used, alone or in combination.

Purpose of the Study:

  • To review the efficacy and dose-limiting toxicities of different chemotherapy regimens used in high-dose chemotherapy with blood progenitor cell transplantation.
  • To highlight the importance of understanding drug-specific toxicity patterns for safe administration.

Main Methods:

  • Review of existing Phase I and II clinical trials.
  • Analysis of drug-specific extramedullary toxicities and dose-limiting factors.

Main Results:

  • Different agents exhibit distinct toxicity profiles (e.g., veno-occlusive disease, pneumonitis, renal failure, mucositis, cardiotoxicity, neurotoxicity).
  • Bone marrow suppression is no longer the primary dose-limiting toxicity due to advances in supportive care.
  • Cyclophosphamide, thiotepa, melphalan, and etoposide allow significant dose escalation, primarily causing mucositis.

Conclusions:

  • Selecting chemotherapy agents with predictable toxicity patterns is essential for high-dose therapy.
  • Clinical pharmacology must be considered to avoid severe extramedullary toxicity and ensure patient safety.

Related Experiment Videos